Clinical Trials Logo

Obstetric Labor, Premature clinical trials

View clinical trials related to Obstetric Labor, Premature.

Filter by:

NCT ID: NCT05971654 Not yet recruiting - Preterm Labor Clinical Trials

Effect Of Azithromycin in Women at Risk of Preterm Labour

Start date: July 30, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of this study is to evaluate the benefit of the addition of azithromycin to standard treatments to prolong pregnancy in women having intact membranes and is at risk of or in preterm labour.

NCT ID: NCT05864066 Not yet recruiting - Preterm Labor Clinical Trials

Cyclin-dependent Kinase Inhibitor 2A (Placental Senescence Marker) on Labor-related Signals

Start date: September 2023
Phase:
Study type: Observational

Onset of labor in human is initiated by progesterone withdrawal. Over many decades researchers had proposed hypotheses to explain the functional withdrawal of progesterone. These hypotheses were through the sequestration of active progesterone by corticosteroid-binding globulin, a decrease in active progesterone metabolite levels and changes in the ratio of progesterone receptor (PR) isoforms (nuclear progesterone receptors A (nPRA) and nuclear progesterone receptors B (nPRB)). Progesterone performs its action non-genomically through binding to membrane receptors and genomically via binding to nPRs. PRA is the less active or inactive form of progesterone receptors and shorter in amino acid sequence than PRB, the active form of the receptors.

NCT ID: NCT05835700 Completed - Clinical trials for Gasdermin D Levels in Preterm Labor

The Relationship Between Serum Gasdermin-D Levels and Pyroptosis and Preterm Labor

Start date: July 15, 2021
Phase: N/A
Study type: Interventional

In this study, the investigators aimed to investigate the relationship between Gasdermin D levels measured from the maternal serum of patients diagnosed with preterm labor and spontaneous preterm labor in pregnant women.

NCT ID: NCT05828966 Completed - Preterm Labor Clinical Trials

HUMAN CHORIONIC GONADOTROPIN (HcG) VS MAGNESIUM SULPHATE (MgSo4) AS A TOCOLYTIC AGENT- A RANDOMIZED CONTROLLED TRIAL

Start date: February 15, 2023
Phase: N/A
Study type: Interventional

Preterm labor is defined as regular contractions of the uterus resulting in changes in the cervix (effacement and dilatation) that start before 37 weeks of pregnancy. (1) Although preterm labor constitutes only 10% of total labors, yet 70% of infant's mortality is related to prematurity. It is therefore one of the international indices in assessment of health condition worldwide. Human Chorionic Gonadotropin (H.C.G.) is a heterodimeric glycoprotein produced primarily in the placenta and has multiple endocrines, paracrine and immunoregulatory actions. (3) The importance of H.C.G. in maintenance of early pregnancy has been widely accepted, reports have highlighted a potential role of H.C.G. in maintaining uterine quiescence in the third trimester. H.C.G. exerts a potent concentration dependent inhibitory effect on human myometrial contractions. (4) Recent data suggests that H.C.G. might have a role as an endogenous tocolytic agent in normal pregnancy. A significant decrease in serum H.C.G. level was found 2-3 weeks before the spontaneous onset of labour. This might contribute to increasing the contractility in the uterine muscle and gradually initiating the onset of labour. (5)

NCT ID: NCT05742997 Recruiting - Preterm Birth Clinical Trials

Evaluation of a Novel Diagnostic Kit for the Detection of Placental Alpha-Microglobulin-1 in the Prediction of Preterm Birth in Women Presenting With Signs and Symptoms of Preterm Labor

PartoSure
Start date: October 1, 2021
Phase: N/A
Study type: Interventional

Currently, the American College of Obstetricians and Gynecologists (ACOG) indicate in their most recent Practice Bulletin on the Management of Preterm Labor that many tests to identify women at risk of preterm birth have been proposed and evaluated; however, only ultrasonography and fetal fibronectin testing have been shown to have benefit. Ultrasonography to determine cervical length, fetal fibronectin testing, or a combination of both may be useful in determining which women are at high risk for preterm delivery. However, their clinical usefulness may rest primarily with their ability to identify women who are least likely to deliver (i.e. their negative predictive value). Therefore, there is an urgent need for a test with a high positive predictive value in order to accurately predict imminent delivery to allow for salutary intervention.

NCT ID: NCT05698966 Recruiting - Preterm Labor Clinical Trials

Low Dose Antenatal Corticosteroids for Late Preterm Delivery

LoDAC
Start date: January 1, 2022
Phase: N/A
Study type: Interventional

This is a study proposal for a clinical trial to evaluate the effectiveness of a reduced dose of antenatal betamethasone (a steroid medication) in preventing respiratory problems in late preterm infants (born between 34 and 36 weeks of gestation). The study will be conducted in medical centers in Israel and will involve women who are at high risk for delivering a late preterm infant. The participants will be randomly assigned to receive either a full dose (12 mg) or a quarter dose (3 mg) of betamethasone, administered 24 hours apart. The main outcome measure of the study will be the incidence of respiratory problems or neonatal death within 72 hours of delivery in the two groups. The study is designed to determine if the reduced dose of betamethasone is non-inferior (i.e., not significantly worse) than the full dose in preventing respiratory problems in late preterm infants.

NCT ID: NCT05688007 Completed - Preterm Labor Clinical Trials

The Association Between Parathyroid Hormone and Preterm Labor

Start date: April 1, 2021
Phase:
Study type: Observational

This observational study aims to test the level of parathyroid hormone in pregnant women. The main question it aims to answer is: n Pregnant women, are the levels of serum PTH, calcium, magnesium, phosphorus & albumin similar in both preterm and term births?

NCT ID: NCT05685745 Recruiting - Premature Birth Clinical Trials

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

Start date: January 1, 2019
Phase:
Study type: Observational [Patient Registry]

The goal of the Tiny Baby Collaborative Multicenter Inventory of Neonatal-Perinatal Interventions (MINI) minimum dataset is to serve as a registry detailing the outcomes and practices for all deliveries and infants admitted to intensive care at 22-23 weeks' gestation at participating hospitals.

NCT ID: NCT05670665 Recruiting - Clinical trials for Obstetric Labor, Premature

Impact of Threatened Preterm Labour in Fetal Cardiovascular and Metabolic Programming (SHs)

SHs
Start date: June 22, 2020
Phase:
Study type: Observational

The goal of this observational study is to learn about cardiac function and remodelling and metabolomic profiles in fetuses and infants who were exposed to a threatened preterm labor (TPL) during pregnancy.

NCT ID: NCT05632003 Completed - Preterm Labor Clinical Trials

Uterocervical Angle in Prediction of Preterm Labor

Preterm labor
Start date: January 1, 2022
Phase:
Study type: Observational

Preterm delivery occurs in about 5-18% of pregnancies before 37 weeks' gestation all over the world.It is associated with a high prevalence of neurological deficits, developmental disabilities and is a leading cause of infant and neonatal mortality. Many of the methods used for predicting preterm birth has not been proven efficacy and is not currently recommended for use.The length of the cervix has been one of the most useful methods in predicting the risk of premature delivery. Detection rates may be improved if combined with other parameters such as the uterocervical angle as a new predictor of spontaneous preterm birth. In this study we will compare between using the uterocervical angle and cervical length in the prediction of preterm labour.